For the Inventor, By the Inventor

Enter assignee name

Secunderabad, India

Matrix Laboratories Limited

Calculating rank

USPTO Granted Patents = 19

% Expired Patents = 36.8

EPO Patents = 8

Forward Citations = 16

Loading Chart...

Loading Chart...

59 inventors (with patents filed for the assignee):

Om Dutt Tyagi (5 out of 7 patents)

Gorantla Seeta Ramanjaneyulu (5 out of 6 patents)

Indukuri Venkata Sunil Kumar (4 out of 4 patents)

4. Seeta Ramanjaneyulu Gorantla (4 out of 16 patents)

5. Satyanarayana Chava (3 out of 36 patents)

6. Purna Chandra Ray (3 out of 3 patents)

7. Madhuresh Kumar Sethi (2 out of 3 patents)

8. Saswata Lahiri (2 out of 2 patents)

9. Chava Satyanarayana (2 out of 3 patents)

10. Ramakoteswara Rao Jetti (2 out of 2 patents)

11. Purandhar Koilkonda (2 out of 2 patents)

12. Jagan Mohana Chary Tummanapally (2 out of 2 patents)

13. Ketavarapu Narasimha Rao (2 out of 2 patents)

14. Jammula Vera Venkata Krishna Kishore (2 out of 2 patents)

15. Debashish Datta (1 out of 7 patents)

19 patents: Sort by Forward Citations

1. 8513427 - Compounds for producing substituted sulfoxides, process for producing the same and use thereof (2013-08-20),

2. 8350030 - Process for producing 5-fluoro-1-(2R, 5S)-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine (2013-01-08),

3. 8329952 - Process for the preparation of O-desmethylvenlafaxine succinate polymorphic forms (2012-12-11),

4. 8318930 - Process for preparing polymorphic forms of (S)-6-chloro-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one (2012-11-27),

5. 8304578 - Process for producing 1-[2-(dimethylamino)-1-(4-phenol)ethyl]cyclohexanol (2012-11-06),

6. 8247568 - Process for the preparation of pure rabeprazole (2012-08-21),

7. 8058453 - Process for the preparation of Carvedilol Form II (2011-11-15),

8. 8049009 - Process for the preparation of Tenofovir (2011-11-01),

9. 8048904 - Process for the preparation of olmesartan medoxomil (2011-11-01),

10. 8026356 - Process for the large scale production of Stavudine (2011-09-27),

11. 7985759 - Dipeptidyl peptidase IV inhibitors and processes for their preparation and pharmaceutical compositions containing them (2011-07-26),

12. 7943784 - Process for the preparation of almotriptan (2011-05-17),

13. 7943780 - Process for the preparation of candesartan cilexetil (2011-05-17),

14. 7884214 - Process for the preparation of Telmisartan (2011-02-08),

15. 7781585 - Crystalline forms of Gatifloxacin (2010-08-24),

Company Overview

Matrix Laboratories Limited is a prominent player in the pharmaceutical industry, specializing in the development and manufacturing of active pharmaceutical ingredients (APIs) and intermediates. The company focuses on a diverse range of therapeutic areas, including anti-infectives, cardiovascular, and central nervous system disorders. With a strong emphasis on research and innovation, Matrix Laboratories is committed to enhancing healthcare solutions globally, leveraging advanced technologies to meet the evolving needs of the pharmaceutical market.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

19 Patents

#1 in Secunderabad

#102 in India

#32,705 in the World

Secunderabad, India

Matrix Laboratories Limited

Forward Citations = 16

59 inventors:

Om Dutt Tyagi (5 out of 7 patents)

Gorantla Seeta Ramanjaneyulu (5 out of 6 patents)

Indukuri Venkata Sunil Kumar (4 out of 4 patents)

4. Seeta Ramanjaneyulu Gorantla (4 out of 16 patents)

5. Satyanarayana Chava (3 out of 36 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Matrix Laboratories Limited. Retrieved from https://idiyas.com/company/matrix-laboratories

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…